• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

年龄相关性黄斑变性和糖尿病性视网膜病变。

Age-Related Macular Degeneration and Diabetic Retinopathy.

作者信息

Ebneter Andreas, Westenskow Peter D

机构信息

Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.

出版信息

J Pers Med. 2022 Apr 5;12(4):581. doi: 10.3390/jpm12040581.

DOI:10.3390/jpm12040581
PMID:35455697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027191/
Abstract

More than 15 years ago, the results of the pivotal trials supporting the intravitreal use of ranibizumab were published [...].

摘要

15年多前，支持玻璃体内注射雷珠单抗的关键试验结果得以发表[……]

相似文献

1
Age-Related Macular Degeneration and Diabetic Retinopathy.年龄相关性黄斑变性和糖尿病性视网膜病变。
J Pers Med. 2022 Apr 5;12(4):581. doi: 10.3390/jpm12040581.
2
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.真实世界中抗 VEGF 药物治疗新生血管性年龄相关性黄斑变性的疗效和成本效果分析：真实世界研究的系统评价和荟萃分析。
Adv Ther. 2020 Jan;37(1):300-315. doi: 10.1007/s12325-019-01147-6. Epub 2019 Nov 14.
3
Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.意大利一家三级转诊医院中抗血管内皮生长因子治疗年龄相关性黄斑变性和糖尿病性黄斑水肿的真实案例
Eur J Ophthalmol. 2020 Nov;30(6):1461-1466. doi: 10.1177/1120672119880386. Epub 2019 Oct 16.
4
Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.玻璃体内注射雷珠单抗治疗年龄相关性黄斑变性中无脉络膜新生血管的有症状性玻璃膜疣样色素上皮脱离。
Clin Ophthalmol. 2011;5:161-5. doi: 10.2147/OPTH.S15832. Epub 2011 Feb 8.
5
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.《糖尿病性黄斑水肿管理的第一议定书实用经验》
Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20.
6
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population.城市人群中接受玻璃体内注射雷珠单抗单药治疗的年龄相关性黄斑变性患者的视力预后
Clin Ophthalmol. 2015 May 28;9:959-65. doi: 10.2147/OPTH.S76754. eCollection 2015.
7
Worth changing? Clinical effects of switching treatment in neovascular age-related macular degeneration from intravitreal ranibizumab and aflibercept to bevacizumab in a region in southern Sweden.在瑞典南部的一个地区，将抗 VEGF 药物雷珠单抗和阿柏西普转换为贝伐单抗治疗新生血管性年龄相关性黄斑变性的临床效果。
Eur J Ophthalmol. 2021 Jan;31(1):144-148. doi: 10.1177/1120672119883602. Epub 2019 Oct 23.
8
Can Vitreous Reflux Affect The Short-Term Treatment Response After Intravitreal Ranibizumab Injection?玻璃体反流会影响玻璃体内注射雷珠单抗后的短期治疗反应吗？
Curr Eye Res. 2021 Feb;46(2):248-254. doi: 10.1080/02713683.2020.1789664. Epub 2020 Jul 7.
9
ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy.ETDRS 全视网膜光凝联合玻璃体内雷珠单抗与 PASCAL 全视网膜光凝联合玻璃体内雷珠单抗与单纯玻璃体内雷珠单抗治疗增生性糖尿病视网膜病变。
Arq Bras Oftalmol. 2020 Nov-Dec;83(6):526-534. doi: 10.5935/0004-2749.20200096.
10
Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.基线糖尿病视网膜病变状态对玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿初始解剖学反应的影响。
Eye (Lond). 2017 Sep;31(9):1358-1364. doi: 10.1038/eye.2017.69. Epub 2017 Apr 28.

引用本文的文献

1
Esophageal Ulcer After Intravitreal Ranibizumab Injection in a Patient With Age-Related Macular Degeneration.玻璃体内注射雷珠单抗治疗年龄相关性黄斑变性患者后出现食管溃疡
Gastroenterology Res. 2023 Apr;16(2):118-124. doi: 10.14740/gr1603. Epub 2023 Apr 28.

本文引用的文献

1
Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature.用于模拟视网膜内微血管系统的微生理神经血管屏障
J Pers Med. 2022 Jan 24;12(2):148. doi: 10.3390/jpm12020148.
2
Correlation of Volume of Macular Edema with Retinal Tomography Features in Diabetic Retinopathy Eyes.糖尿病视网膜病变眼中黄斑水肿体积与视网膜断层扫描特征的相关性
J Pers Med. 2021 Dec 9;11(12):1337. doi: 10.3390/jpm11121337.
3
miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema.微小RNA水平作为糖尿病性黄斑水肿患者抗血管内皮生长因子治疗反应的生物标志物
J Pers Med. 2021 Dec 4;11(12):1297. doi: 10.3390/jpm11121297.
4
Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration.补体系统的半定量多重分析确定了补体蛋白与年龄相关性黄斑变性中的基因变异和代谢物之间的关联。
J Pers Med. 2021 Nov 25;11(12):1256. doi: 10.3390/jpm11121256.
5
Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years.新生血管性年龄相关性黄斑变性中的特异性自身抗体：五年间形态学和功能进展评估
J Pers Med. 2021 Nov 16;11(11):1207. doi: 10.3390/jpm11111207.
6
Quantitative Imaging Biomarkers in Age-Related Macular Degeneration and Diabetic Eye Disease: A Step Closer to Precision Medicine.年龄相关性黄斑变性和糖尿病眼病中的定量成像生物标志物：向精准医学迈进了一步。
J Pers Med. 2021 Nov 8;11(11):1161. doi: 10.3390/jpm11111161.
7
The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept.RECOVERY研究的2年渗漏指数和定量微动脉瘤结果：玻璃体内注射阿柏西普治疗增殖性糖尿病视网膜病变的定量超广角研究结果
J Pers Med. 2021 Nov 1;11(11):1126. doi: 10.3390/jpm11111126.
8
Association between Retinal Thickness Variability and Visual Acuity Outcome during Maintenance Therapy Using Intravitreal Anti-Vascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration.玻璃体内注射抗血管内皮生长因子药物治疗新生血管性年龄相关性黄斑变性维持治疗期间视网膜厚度变异性与视力结果的相关性
J Pers Med. 2021 Oct 14;11(10):1024. doi: 10.3390/jpm11101024.
9
Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial.实时糖尿病视网膜病变严重程度评分水平与超广角渗漏指数引导的糖尿病视网膜病变管理：随机PRIME试验的两年结果
J Pers Med. 2021 Sep 4;11(9):885. doi: 10.3390/jpm11090885.
10
Characterization of Risk Profiles for Diabetic Retinopathy Progression.糖尿病视网膜病变进展风险特征的描述
J Pers Med. 2021 Aug 23;11(8):826. doi: 10.3390/jpm11080826.